Figure 5
From: KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer
The relationship between KMT2C mutations and microsatellite status (A) or tumor mutational burden (B) or PD-L1 status (C) in the 3Dcohort. (D) Pie charts of KMT2C mutations sites.
